Sep 14, 2016
ISCoS meeting 2016

Initial Clinical Trials of hESC-Derived Oligodendrocyte Progenitor Cells in Subacute Spinal Cord Injury

May 30, 2015
Khoury et al ASCO AST-VAC1 Presentation

Long-term Follow-up of Patients with Acute Myelogenous Leukemia Receiving an Autologous Telomerase-based Dendritic Cell Vaccine

May 22, 2014
American Society for Gene and Cell Therapy Annual Meeting, Washington, DC

Phase I Clinical Trial of Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors in Patients with Neurologically Complete Thoracic Spinal Cord Injury: Results and Next Steps